DK2092935T3 - Farmaceutiske sammensætninger til behandling astma - Google Patents

Farmaceutiske sammensætninger til behandling astma

Info

Publication number
DK2092935T3
DK2092935T3 DK09006110.2T DK09006110T DK2092935T3 DK 2092935 T3 DK2092935 T3 DK 2092935T3 DK 09006110 T DK09006110 T DK 09006110T DK 2092935 T3 DK2092935 T3 DK 2092935T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
treating asthma
asthma
treating
pharmaceutical
Prior art date
Application number
DK09006110.2T
Other languages
English (en)
Inventor
Joel A Sequeira
John L Hart
Stefan A Sharpe
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23224164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2092935(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK2092935T3 publication Critical patent/DK2092935T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK09006110.2T 2001-08-28 2002-08-27 Farmaceutiske sammensætninger til behandling astma DK2092935T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31538601P 2001-08-28 2001-08-28
EP02753549A EP1420759B1 (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma

Publications (1)

Publication Number Publication Date
DK2092935T3 true DK2092935T3 (da) 2011-07-18

Family

ID=23224164

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02753549T DK1420759T3 (da) 2001-08-28 2002-08-27 Farmaceutiske sammensætninger til behandling af astma
DK09006110.2T DK2092935T3 (da) 2001-08-28 2002-08-27 Farmaceutiske sammensætninger til behandling astma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02753549T DK1420759T3 (da) 2001-08-28 2002-08-27 Farmaceutiske sammensætninger til behandling af astma

Country Status (26)

Country Link
US (3) US20030114428A1 (da)
EP (3) EP1420759B1 (da)
JP (3) JP2005502675A (da)
KR (1) KR100970531B1 (da)
CN (2) CN1649568B (da)
AR (1) AR036358A1 (da)
AT (2) ATE430555T1 (da)
AU (1) AU2002313828B2 (da)
BR (1) BR0212089A (da)
CA (1) CA2457926A1 (da)
CO (1) CO5560551A2 (da)
CY (2) CY1109212T1 (da)
DE (2) DE60239648D1 (da)
DK (2) DK1420759T3 (da)
ES (3) ES2389480T3 (da)
HU (1) HUP0401514A3 (da)
MX (1) MXPA04001875A (da)
NO (1) NO20041277L (da)
NZ (1) NZ530987A (da)
PE (1) PE20030390A1 (da)
PL (1) PL209640B1 (da)
PT (2) PT1420759E (da)
SI (2) SI1420759T1 (da)
TW (1) TWI324934B (da)
WO (1) WO2003020253A2 (da)
ZA (1) ZA200401419B (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
ATE375142T1 (de) * 2001-03-30 2007-10-15 Jagotec Ag Medizinische aerosolformulierungen
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
EP1785156B1 (en) * 2002-08-23 2012-06-27 Schering Corporation Metered dose inhaler containing an aerosol suspension formulation
CA2495689A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions
WO2004020289A1 (en) * 2002-08-27 2004-03-11 Schering Corporation Process for producing metered dose inhaler formulations
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
CA2542530A1 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
EP2201936B1 (en) * 2004-01-21 2013-06-19 Merck Sharp & Dohme Corp. Method of treating acute rhinosinusitis
US20110053999A1 (en) 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
EP1811981B1 (en) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
WO2006105401A2 (en) 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
EP1981545A2 (en) * 2006-02-09 2008-10-22 Schering Corporation Pharmaceutical formulations
EP2117504A1 (en) * 2007-02-09 2009-11-18 Schering Corporation Stable pharmaceutical drug aerosols
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
GB0714239D0 (en) * 2007-07-20 2007-08-29 Glaxo Group Ltd Method
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
MX2010007569A (es) * 2008-01-10 2011-03-21 Schering Corp Star Productos farmaceuticos para inhalacion, sistemas y usos.
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
AU2010253770B9 (en) * 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
KR101464053B1 (ko) * 2009-12-07 2014-11-20 랩터 세라퓨틱스 인크. 4-메틸피라졸 배합물
WO2011101830A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
PH12012501666A1 (en) 2010-02-22 2012-11-05 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - betamethasone dipropionate, and a process to make it
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012017368A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
WO2012049543A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
CA2850084C (en) 2011-10-11 2020-07-07 Chiesi Farmaceutici S.P.A. Crystalline microparticles of a beta-agonist coated with a fatty acid
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
BR122022010094B1 (pt) 2014-05-07 2023-10-03 Boehringer Ingelheim International Gmbh Dispositivo indicador e recipiente
MX383195B (es) 2014-05-07 2025-03-13 Boehringer Ingelheim Int Recipiente, nebulizador y uso.
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
WO2016004103A1 (en) 2014-06-30 2016-01-07 Proveris Scientific Company Sampling apparatus for determining the amount and uniformity of a delivered dose of drug related methods
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3701940B1 (en) 2015-12-04 2025-11-12 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
EP3426329A4 (en) 2016-03-09 2019-11-13 Proveris Scientific Corporation METHOD FOR MEASURING THE UNITABILITY OF THE DOSE CONTENT OF INHALATION AND NOSING DEVICES
CN106619658B (zh) * 2016-12-28 2022-02-08 四川普锐特药业有限公司 一种医用气溶胶制剂及定量吸入气雾剂
US20210338626A1 (en) 2020-04-28 2021-11-04 Dalcor Pharma Uk Ltd., Leatherhead, Zug Branch Methods for treating or preventing a viral infection or inhibiting viral replication
CN116583316A (zh) 2020-10-15 2023-08-11 普罗沃锐斯科学有限公司 用于吸入器测试的系统和方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
ES2200771T3 (es) * 1991-06-10 2004-03-16 Schering Corporation Formulaciones en aerosol no clorofluorocarbonadas.
US6250300B1 (en) * 1992-12-11 2001-06-26 Ab Astra System for dispensing pharmaceutically active compounds
WO1996019198A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
EP0927037B1 (en) * 1996-08-29 2001-07-11 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
EP1133301A1 (en) * 1998-11-26 2001-09-19 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
ES2220724T3 (es) * 2000-01-20 2004-12-16 Basilea Pharmaceutica Ag Composiciones de peptidos ciclicos administrables por via nasal.
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
TW200301698A (en) * 2001-12-21 2003-07-16 Bristol Myers Squibb Co Acridone inhibitors of IMPDH enzyme

Also Published As

Publication number Publication date
DE60232251D1 (de) 2009-06-18
EP2092935B1 (en) 2011-03-30
HUP0401514A2 (hu) 2004-12-28
JP5170789B2 (ja) 2013-03-27
PT2092935E (pt) 2011-05-31
MXPA04001875A (es) 2004-06-15
EP1420759A2 (en) 2004-05-26
NO20041277L (no) 2004-03-26
ES2361805T3 (es) 2011-06-22
CY1111726T1 (el) 2015-10-07
JP2005502675A (ja) 2005-01-27
EP2092935A1 (en) 2009-08-26
US20100143269A1 (en) 2010-06-10
PL368897A1 (en) 2005-04-04
TWI324934B (en) 2010-05-21
BR0212089A (pt) 2004-08-03
CN101856362A (zh) 2010-10-13
CN1649568B (zh) 2010-10-27
EP1420759B1 (en) 2009-05-06
ES2389480T3 (es) 2012-10-26
CN1649568A (zh) 2005-08-03
EP2319494A1 (en) 2011-05-11
DE60239648D1 (de) 2011-05-12
ZA200401419B (en) 2005-01-26
KR20040031002A (ko) 2004-04-09
HK1060972A1 (en) 2004-09-03
EP2319494B1 (en) 2012-06-13
ATE430555T1 (de) 2009-05-15
PL209640B1 (pl) 2011-09-30
AU2002313828B2 (en) 2005-09-08
CA2457926A1 (en) 2003-03-13
DK1420759T3 (da) 2009-08-03
HUP0401514A3 (en) 2012-08-28
JP2009185075A (ja) 2009-08-20
JP2010138184A (ja) 2010-06-24
ATE503461T1 (de) 2011-04-15
CO5560551A2 (es) 2005-09-30
AR036358A1 (es) 2004-09-01
PT1420759E (pt) 2009-06-30
PE20030390A1 (es) 2003-04-24
KR100970531B1 (ko) 2010-07-16
SI2092935T1 (sl) 2011-07-29
ES2325316T3 (es) 2009-09-01
HK1128428A1 (en) 2009-10-30
HK1151987A1 (en) 2012-02-17
US20030114428A1 (en) 2003-06-19
US20050147565A1 (en) 2005-07-07
CY1109212T1 (el) 2014-07-02
WO2003020253A3 (en) 2003-05-22
WO2003020253A2 (en) 2003-03-13
SI1420759T1 (sl) 2009-10-31
NZ530987A (en) 2006-08-31

Similar Documents

Publication Publication Date Title
DK1420759T3 (da) Farmaceutiske sammensætninger til behandling af astma
FI20011478L (fi) Farmaseuttinen koostumus
EP1391476A4 (en) PHOTOREACTIVE COMPOSITION
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
EP1466610A4 (en) MEDICAL COMPOSITIONS FOR RECEIVING VIA THE NOSE
EE200300416A (et) Ravimvorm
DK1666070T3 (da) Præparat til restenoseprofylakse
IS7261A (is) N-adamantýlmetýlafleiður og milliefni sem lyfjablöndur og aðferðir til að framleiða þær
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
EE200300589A (et) Ravimkoostised
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
FI20022128A7 (fi) Farmaseuttinen koostumus
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
EP1408896A4 (en) PHARMACEUTICAL COMPOSITION
NO20034556L (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
EP1389467A4 (en) THERAPEUTIC COMPOSITIONS FOR THE REPAIR OF CHONDROPATHY
NO20043489L (no) Sammensetning for inhalering
HUP0200253A3 (en) Pharmaceutical compositions for combination therapy
PT1372636E (pt) Dosagem metronomica para taxanos
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
NO20044164L (no) Farmasoytiske sammensetninger
PL364467A1 (en) Pharmaceutical composition
EP1413314A4 (en) MEDICAL COMPOSITIONS
FI5468U1 (fi) Farmaseuttinen koostumus
DK2105135T3 (da) Farmaceutiske sammensætninger til behandling af cancer